GeoVax Labs Free Cash Flow (FCF) History (GOVX)
GeoVax Labs reported −$21.5M in free cash flow for fiscal 2025, an increase of $3.2M from the previous fiscal year, with a free cash flow margin of −863.81%.
View full GeoVax Labs company overviewGeoVax Labs free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$21.5M | $3.2M | — | −863.81% |
| 2024 | 2024-12-31 | −$24.7M | $526,421 | — | −624.50% |
| 2023 | 2023-12-31 | −$25.2M | −$6.1M | — | — |
| 2022 | 2022-12-31 | −$19.2M | −$7.9M | — | −23507.18% |
| 2021 | 2021-12-31 | −$11.2M | −$8.3M | — | −2916.76% |
| 2020 | 2020-12-31 | −$2.9M | −$1.5M | — | −159.42% |
| 2019 | 2019-12-31 | −$1.4M | $286,711 | — | −119.58% |
| 2017 | 2017-12-31 | −$1.7M | $1.0M | — | −157.43% |
| 2015 | 2015-12-31 | −$2.7M | −$435,503 | — | — |
| 2014 | 2014-12-31 | −$2.3M | −$504,415 | — | — |
| 2013 | 2013-12-31 | −$1.8M | −$1.5M | — | — |
| 2011 | 2011-12-31 | −$315,517 | $2.1M | — | — |
| 2010 | 2010-12-31 | −$2.4M | −$746,881 | — | — |
| 2009 | 2009-12-31 | −$1.7M | — | — | — |
GeoVax Labs quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$3.7M | $687,013 | — | — |
| Q1 2026 | 2026-03-31 | −$3.5M | $2.4M | — | — |
| Q4 2025 | 2025-12-31 | −$5.0M | $2.8M | — | — |
| Q3 2025 | 2025-09-30 | −$6.2M | $3.1M | — | — |
| Q2 2025 | 2025-06-30 | −$4.3M | −$2.4M | — | −509.82% |
| Q1 2025 | 2025-03-31 | −$6.0M | −$298,844 | — | −365.49% |
| Q4 2024 | 2024-12-31 | −$7.8M | $2.5M | — | −896.97% |
| Q3 2024 | 2024-09-30 | −$9.3M | −$4.2M | — | −334.03% |
| Q2 2024 | 2024-06-30 | −$1.9M | $4.1M | — | −645.56% |
| Q1 2024 | 2024-03-31 | −$5.7M | −$1.9M | — | — |
| Q4 2023 | 2023-12-31 | −$10.3M | −$3.2M | — | — |
| Q3 2023 | 2023-09-30 | −$5.1M | −$1.3M | — | — |
| Q2 2023 | 2023-06-30 | −$6.1M | −$2.2M | — | — |
| Q1 2023 | 2023-03-31 | −$3.8M | $632,554 | — | — |
| Q4 2022 | 2022-12-31 | −$7.1M | −$381,087 | — | — |
| Q3 2022 | 2022-09-30 | −$3.9M | −$2.2M | — | — |
| Q2 2022 | 2022-06-30 | −$3.9M | −$2.6M | — | — |
| Q1 2022 | 2022-03-31 | −$4.4M | −$2.8M | — | −5391.44% |
| Q4 2021 | 2021-12-31 | −$6.7M | −$6.4M | — | −4051.33% |
| Q3 2021 | 2021-09-30 | −$1.7M | −$1.4M | — | −5462.92% |
| Q2 2021 | 2021-06-30 | −$1.3M | −$934,540 | — | −1603.94% |
| Q1 2021 | 2021-03-31 | −$1.6M | −$1.2M | — | −1468.10% |
| Q3 2020 | 2020-09-30 | −$285,596 | $36,037 | — | −68.74% |
| Q4 2019 | 2019-12-31 | −$284,094 | $164,349 | — | −105.80% |
| Q3 2019 | 2019-09-30 | −$343,928 | $134,843 | — | −103.22% |
| Q2 2019 | 2019-06-30 | −$456,448 | −$27,296 | — | −217.42% |
| Q1 2019 | 2019-03-31 | −$321,633 | $14,815 | — | −88.30% |
| Q4 2017 | 2017-12-31 | −$448,443 | $312,247 | — | −249.96% |
| Q3 2017 | 2017-09-30 | −$478,771 | $175,918 | — | −193.06% |
| Q2 2017 | 2017-06-30 | −$429,152 | $241,850 | — | −121.87% |
| Q1 2017 | 2017-03-31 | −$336,448 | $298,284 | — | −113.77% |
| Q4 2015 | 2015-12-31 | −$760,690 | −$251,079 | — | — |
| Q3 2015 | 2015-09-30 | −$654,689 | — | — | — |
| Q2 2015 | 2015-06-30 | −$671,002 | — | — | — |
| Q1 2015 | 2015-03-31 | −$634,732 | — | — | — |
| Q3 2014 | 2014-09-30 | −$509,611 | — | — | — |
GeoVax Labs free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$2.9M to −$21.5M, a net decrease of $18.6M. GeoVax Labs's latest reported quarter, Q2 2026, generated −$3.7M in free cash flow, an increase of $687,013 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review GeoVax Labs filings at SEC.gov ↗